Genmab A/s Earnings

Genmab A/s’s revenue jumped 19.06% since last year same period to $4932.69Mn in the Q1 2025. On a quarterly growth basis, Genmab A/s has generated -23.42% fall in its revenue since last 3-months.

Genmab A/s’s net profit fell -85.28% since last year same period to $195Mn in the Q1 2025. On a quarterly growth basis, Genmab A/s has generated -94.93% fall in its net profits since last 3-months.

Genmab A/s’s net profit margin fell -87.64% since last year same period to 3.95% in the Q1 2025. On a quarterly growth basis, Genmab A/s has generated -93.38% fall in its net profit margins since last 3-months.

Genmab A/s’s price-to-earnings ratio after this Q1 2025 earnings stands at 12.86.

Genmab A/s’s earning per share (EPS) estimates for the current quarter stand at 0.42 - a 8.08% jump from last quarter’s estimates.

Genmab A/s’s earning per share (EPS) estimates for the current year stand at 0.42.

Genmab A/s’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Genmab A/s has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.